|
|
41
|
|
|
66721
|
|
|
CATAFLAM 1.8MG/ML SUSP (NVS) DICLOFENAC (C)
|
|
|
DICLOFENAC POTASSIUM
|
|
|
CATAFLAM
|
|
|
120ML
|
|
|
C
|
|
|
9.62
|
|
|
0.0802
|
|
|
1.8MG/ML
|
|
|
ML
|
|
|
120
|
|
|
BOTT
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2024-04-01
|
|
|
2025-01-20
|
|
|
|
|
|
|
|
|
1 TD
|
|
|
3
|
|
|
Y
|
|
|
28080492
|
|
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
|
ORAL
|
|
|
0
|
|
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
2024-12-09
|